Universal Detection signs deal with U.S. to become Featured U.S. Exporter of bioterrorism monitoring equipment in France

Universal Detection Technology (www.udetection.com) (OTCBB:UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that the company has entered an agreement with U.S. Department of Commerce's Commercial Service to become a Featured U.S. Exporter (FUSE) of bioterrorism monitoring equipment in France.

Universal Detection Technology’s handheld assays, currently used by the U.S. Department of Defense, government agencies and commercial business for the detection of up to five bioterrorism agents, will be listed as a Featured U.S. Exporter on Commercial Service's French website:

UNDT's 5-agent Bioterrorism detection kits have been extensively used by first responders and private industry throughout the United States. Testing of the kits by the U.S. DOD as well as the United Kingdom military show that the kits demonstrate no cross-reactivity with near neighbor species and no false positives with commonly encountered "white powders". The kits are designed to test for anthrax, botulinum toxin, Ricin, plague (Y. Pestis) and SEB's in as little as three minutes.

Universal Detection Technology is exhibiting its bio-terror detection equipment at the upcoming 2009 Milipol Conference in Paris, France, November 17-20.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered MRI predicts outcomes in prostate cancer